HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hydrogen sulfide prevents arterial medial calcification in rats with diabetic nephropathy.

AbstractBACKGROUND:
Arterial medial calcification (AMC) is associated with a high incidence of cardiovascular risk in patients with type 2 diabetes and chronic kidney disease. Here, we tested whether hydrogen sulfide (H2S) can prevent AMC in rats with diabetic nephropathy (DN).
METHODS:
DN was induced by a single injection of streptozotocin and high-fat diet (45% kcal as fat) containing 0.75% adenine in Sprague-Dawley rats for 8 weeks.
RESULTS:
Rats with DN displayed obvious calcification in aorta, and this was significantly alleviated by Sodium Hydrosulfide (NaHS, a H2S donor, 50 μmol/kg/day for 8 weeks) treatment through decreasing calcium and phosphorus content, ALP activity and calcium deposition in aorta. Interestingly, the main endogenous H2S generating enzyme activity and protein expression of cystathionine-γ-lyase (CSE) were largely reduced in the arterial wall of DN rats. Exogenous NaHS treatment restored CSE activity and its expression, inhibited aortic osteogenic transformation by upregulating phenotypic markers of smooth muscle cells SMα-actin and SM22α, and downregulating core binding factor α-1 (Cbfα-1, a key factor for bone formation), protein expressions in rats with DN when compared to the control group. NaHS administration also significantly reduced Stat3 activation, cathepsin S (CAS) activity and TGF-β1 protein level, and improved aortic elastin expression.
CONCLUSIONS:
H2S may have a clinical significance for treating AMC in people with DN by reducing Stat3 activation, CAS activity, TGF-β1 level and increasing local elastin level.
AuthorsFang-Zheng Wang, Hong Zhou, Hong-Yu Wang, Hang-Bing Dai, Qing Gao, Pei Qian, Ye-Bo Zhou
JournalBMC cardiovascular disorders (BMC Cardiovasc Disord) Vol. 21 Issue 1 Pg. 495 (10 13 2021) ISSN: 1471-2261 [Electronic] England
PMID34645391 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2021. The Author(s).
Chemical References
  • STAT3 Transcription Factor
  • Stat3 protein, rat
  • Tgfb1 protein, rat
  • Transforming Growth Factor beta1
  • Elastin
  • Cathepsins
  • cathepsin S
  • Hydrogen Sulfide
Topics
  • Animals
  • Aorta (drug effects, metabolism, pathology)
  • Aortic Diseases (etiology, metabolism, pathology, prevention & control)
  • Cathepsins (metabolism)
  • Diabetic Nephropathies (complications, drug therapy, metabolism)
  • Disease Models, Animal
  • Elastin (metabolism)
  • Hydrogen Sulfide (pharmacology)
  • Male
  • Rats, Sprague-Dawley
  • STAT3 Transcription Factor (metabolism)
  • Transforming Growth Factor beta1 (metabolism)
  • Tunica Media (drug effects, metabolism, pathology)
  • Vascular Calcification (etiology, metabolism, pathology, prevention & control)
  • Rats

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: